/CBDG

CBDG Stock - THC Farmaceuticals, Inc.

Q: What is the analyst price target for CBDG?

Analyst price target information is not currently available for CBDG.

Q: What is CBDG's market cap?

Market capitalization information is not currently available for CBDG.

Healthcare|Biotechnology|OTC

$0.01-60.53%

$0.02 (-60.53%) • Dec 19

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

100

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $0.02

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for CBDG

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2019

FY2020

FY2021

FY2022

FY2023

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta-9.64

52W High$0.10

52W Low$0.00

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2023	FY2022	FY2021	FY2020	FY2019
Revenue	N/A	$10,000	$2,234	$7,575	$10,193
Gross Profit	$-4,952	$6,192	$1,282	$7,575	$7,559
Gross Margin	N/A	61.9%	57.4%	100.0%	74.2%
Operating Income	$-29,952	$-8,491	$-17,810	$-32,700	$-158,090
Net Income	$-14,976	$426,905	$-8,420	$-60,445	$-498,566
Net Margin	N/A	4269.1%	-376.9%	-798.0%	-4891.3%
EPS	$-0.00	$0.02	$-0.00	$-0.00	$-0.03

Company Overview

THC Farmaceuticals, Inc. owns and operates non-financial institution cash-dispensing automated teller machines at third-party owned retail and commercial locations. The company's machines are placed in hotels, stores, bowling alleys, and other high customer traffic areas for small and medium sized businesses. As of June 30, 2015, it had a total of eight machines for public use along the Wasatch Front in the State of Utah. The company was formerly known as City Media, Inc. and changed its name to THC Farmaceuticals, Inc. in February 2015. THC Farmaceuticals, Inc. was founded in 2008 and is based in Scottsdale, Arizona. THC Farmaceuticals, Inc. operates as a subsidiary of Weed Growth Fund, Inc.

Visit Website

Frequently Asked Questions about CBDG

What is CBDG's current stock price?

THC Farmaceuticals, Inc. (CBDG) is currently trading at $0.01 per share. The stock has moved -60.53% today.

What is the analyst price target for CBDG?

No analyst price targets are currently available for this stock.

What sector is THC Farmaceuticals, Inc. in?

THC Farmaceuticals, Inc. operates in the Healthcare sector, specifically within the Biotechnology industry. The company is traded on the OTC exchange.

What is CBDG's market cap?

THC Farmaceuticals, Inc. has a market capitalization of $0.00 billion, making it a small-cap company.

Does CBDG pay dividends?

No, THC Farmaceuticals, Inc. does not currently pay a dividend to shareholders.